FRA:QIA - Deutsche Boerse Ag - NL0015002CX3 - Common Stock - Currency: EUR
FRA:QIA (5/30/2025, 7:00:00 PM)
39.75
+0.19 (+0.48%)
The current stock price of QIA.DE is 39.75 EUR. In the past month the price increased by 4.87%. In the past year, price decreased by -1.84%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 18.5 | 134.82B | ||
1TMO.MI | THERMO FISHER SCIENTIFIC INC | 18.11 | 132.03B | ||
DAP.DE | DANAHER CORP | 25.46 | 119.72B | ||
LO3.DE | LONZA GROUP AG-REG | 38.03 | 44.15B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 51.05 | 18.88B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 50.79 | 18.78B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 49.41 | 15.80B | ||
SRT.DE | SARTORIUS AG | 40.42 | 12.92B | ||
ILU.DE | ILLUMINA INC | 24.8 | 11.54B | ||
ERF.PA | EUROFINS SCIENTIFIC | 32.63 | 10.70B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 32.53 | 10.67B | ||
1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 29.08 | 4.29B |
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 5,765 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
QIAGEN N.V.
Hulsterweg 82
Venlo LIMBURG NL
Employees: 5765
Phone: 31773556600
The current stock price of QIA.DE is 39.75 EUR. The price increased by 0.48% in the last trading session.
The exchange symbol of QIAGEN N.V. is QIA and it is listed on the Deutsche Boerse Ag exchange.
QIA.DE stock is listed on the Deutsche Boerse Ag exchange.
25 analysts have analysed QIA.DE and the average price target is 44.8 EUR. This implies a price increase of 12.71% is expected in the next year compared to the current price of 39.75. Check the QIAGEN N.V. stock analysts ratings, price target forecast and up-and down grades for more detailed information.
QIAGEN N.V. (QIA.DE) has a market capitalization of 8.61B EUR. This makes QIA.DE a Mid Cap stock.
QIAGEN N.V. (QIA.DE) currently has 5765 employees.
QIAGEN N.V. (QIA.DE) has a support level at 38.33 and a resistance level at 39.76. Check the full technical report for a detailed analysis of QIA.DE support and resistance levels.
The Revenue of QIAGEN N.V. (QIA.DE) is expected to grow by 4.01% in the next year. Check the estimates tab for more information on the QIA.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
QIA.DE does not pay a dividend.
QIAGEN N.V. (QIA.DE) will report earnings on 2025-07-31, after the market close.
The PE ratio for QIAGEN N.V. (QIA.DE) is 19.58. This is based on the reported non-GAAP earnings per share of 2.03 and the current share price of 39.75 EUR. Check the full fundamental report for a full analysis of the valuation metrics for QIA.DE.
ChartMill assigns a technical rating of 6 / 10 to QIA.DE. When comparing the yearly performance of all stocks, QIA.DE turns out to be only a medium performer in the overall market: it outperformed 62.08% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to QIA.DE. While QIA.DE has a great health rating, its profitability is only average at the moment.
Over the last trailing twelve months QIA.DE reported a non-GAAP Earnings per Share(EPS) of 2.03. The EPS increased by 11.95% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.23% | ||
ROA | 1.47% | ||
ROE | 2.34% | ||
Debt/Equity | 0.38 |
ChartMill assigns a Buy % Consensus number of 76% to QIA.DE. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 8.07% and a revenue growth 4.01% for QIA.DE